251 related articles for article (PubMed ID: 11068697)
1. Nimesulide and beta-cyclodextrin inclusion complexes: physicochemical characterization and dissolution rate studies.
Chowdary KP; Nalluri BN
Drug Dev Ind Pharm; 2000 Nov; 26(11):1217-20. PubMed ID: 11068697
[TBL] [Abstract][Full Text] [Related]
2. Inclusion complexation of nimesulide with beta-cyclodextrins.
Vavia PR; Adhage NA
Drug Dev Ind Pharm; 1999 Apr; 25(4):543-5. PubMed ID: 10194611
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systems.
Nalluri BN; Chowdary KP; Murthy KV; Hayman AR; Becket G
AAPS PharmSciTech; 2003; 4(1):E2. PubMed ID: 12916912
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of quercetin and rutin cyclodextrin inclusion complexes.
Sri KV; Kondaiah A; Ratna JV; Annapurna A
Drug Dev Ind Pharm; 2007 Mar; 33(3):245-53. PubMed ID: 17454057
[TBL] [Abstract][Full Text] [Related]
5. Rofecoxib-beta-cyclodextrin inclusion complex for solubility enhancement.
Rawat S; Jain SK
Pharmazie; 2003 Sep; 58(9):639-41. PubMed ID: 14531460
[TBL] [Abstract][Full Text] [Related]
6. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
Rawat S; Jain SK
Eur J Pharm Biopharm; 2004 Mar; 57(2):263-7. PubMed ID: 15018983
[TBL] [Abstract][Full Text] [Related]
7. Beta-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies.
Reddy MN; Rehana T; Ramakrishna S; Chowdhary KP; Diwan PV
AAPS PharmSci; 2004 Mar; 6(1):E7. PubMed ID: 15198508
[TBL] [Abstract][Full Text] [Related]
8. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
9. Solubility, Permeability, Anti-Inflammatory Action and In Vivo Pharmacokinetic Properties of Several Mechanochemically Obtained Pharmaceutical Solid Dispersions of Nimesulide.
Wei W; Evseenko VI; Khvostov MV; Borisov SA; Tolstikova TG; Polyakov NE; Dushkin AV; Xu W; Min L; Su W
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802031
[TBL] [Abstract][Full Text] [Related]
10. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
[TBL] [Abstract][Full Text] [Related]
11. Nimesulide/methyl β-cyclodextrin inclusion complexes: physicochemical characterization, solubility, dissolution, and biological studies.
Auda SH
Drug Dev Res; 2014 Mar; 75(2):68-75. PubMed ID: 24648149
[TBL] [Abstract][Full Text] [Related]
12. Study of the influence of both cyclodextrins and L-lysine on the aqueous solubility of nimesulide; isolation and characterization of nimesulide-L-lysine-cyclodextrin complexes.
Piel G; Pirotte B; Delneuville I; Neven P; Llabres G; Delarge J; Delattre L
J Pharm Sci; 1997 Apr; 86(4):475-80. PubMed ID: 9109052
[TBL] [Abstract][Full Text] [Related]
13. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
14. Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.
Semcheddine F; Guissi Nel I; Liu X; Wu Z; Wang B
AAPS PharmSciTech; 2015 Jun; 16(3):704-15. PubMed ID: 25511809
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical characterization and in vitro dissolution behaviour of celecoxib-beta-cyclodextrin inclusion complexes.
Sinha VR; Anitha R; Ghosh S; Amita ; Kumria R; Bhinge JR; Kumar M
Acta Pharm; 2007 Mar; 57(1):47-60. PubMed ID: 19839406
[TBL] [Abstract][Full Text] [Related]
16. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
Semalty M; Panchpuri M; Singh D; Semalty A
Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
Patel SG; Rajput SJ
AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
[TBL] [Abstract][Full Text] [Related]
19. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
Mura P; Faucci MT; Bettinetti GP
Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
[TBL] [Abstract][Full Text] [Related]
20. Study of tolbutamide-hydroxypropyl-gamma-cyclodextrin interaction in solution and solid state.
Veiga MD; Ahsan F
Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):793-7. PubMed ID: 10866138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
